What is Cannabis Global Inc?
focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body.
CBGL · Verdict
Limited reward · high risk
CBGL has limited near-term tailwinds — cash flow and volatility weigh on the model output.
Based on 88% data coverage
CBGL · Verdict
Weak vs peers
Weak vs peers
-67% return on equity
Current ratio 0.05
Earnings -73.3% CAGR
Model-based scoring. For information only — not financial advice.
focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body. The company offers cannabis flower packaged, pre-rolls, and edible products to cannabis retailers and distributors; and Comply Bag, a solution for cannabis storage, transport, and tracking. The company is listed on the PINK in USA, operating in the Healthcare sector, with a market capitalisation of 656.42K.
The scoring profile indicates weak reward characteristics across most factors, including valuation and momentum. Risk indicators are high — this profile reflects meaningful downside exposure.
For informational purposes only. Not financial advice.